A key achievement of the project has been the synthesis of Pd1@TRIDAP, which combines precision catalyst design with scalable synthetic strategies. The catalyst was successfully prepared via an organoligand-based polymerization process, ensuring atomic dispersion and site isolation of palladium centers within a well-defined organic matrix. Advanced spectroscopic techniques, including XPS, XAS, and TEM, confirmed the structural integrity and electronic environment of the active sites, while DFT calculations provided insight into their stability and mechanistic role in catalytic processes. The application of Pd1@TRIDAP in C–C coupling and CO2 valorization has demonstrated unprecedented selectivity and recyclability, with experimental findings corroborated by first-principles modeling. In particular, the catalyst has enabled the self-cascade Suzuki coupling reaction, eliminating the need for intermediate purification and setting the stage for more complex tandem catalytic transformations. Furthermore, its implementation in one-pot pharmaceutical synthesis highlights its versatility in constructing bioactive molecules under streamlined reaction conditions. These results have suggested a broader potential for SACs in fine chemical and pharmaceutical manufacturing, in order to bridge the gap between fundamental research and industrial application.